Cargando…

非小细胞肺癌患者K-RAS基因突变的研究

BACKGROUND AND OBJECTIVE: Recent studies indicated that Non-small cell lung cancer (NSCLC) patients with mutant K-RAS failed to benefit from adjuvant chemotherapy, and the cancer did not respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). These findings indicated th...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015157/
https://www.ncbi.nlm.nih.gov/pubmed/20681447
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.06.007

Ejemplares similares